LNC
CDLX icon

Lincoln National Corp’s Cardlytics CDLX Stock Holding History

Lincoln National Corp’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-400
Closed -$220K – 870
2022
Q1 		$220K Hold
400
– – ﹤0.01% 825
2021
Q4 		$264K Buy
+400
New +$306K 0.01% 760

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Lincoln National Corp's CDLX Position: Q2 2022 in Review

Lincoln National Corp sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 400 shares — an estimated $220K sold.

Lincoln National Corp first reported a position in CDLX in Q4 2021 and held it in 2 quarters. The position peaked at $264K in Q4 2021. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • Lincoln National Corp reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • Lincoln National Corp sold 400 Cardlytics shares in Q2 2022, an estimated $220K.
  • Lincoln National Corp first reported a position in Cardlytics in Q4 2021 and held it in 2 quarters.
  • Lincoln National Corp's Cardlytics position peaked at $264K in Q4 2021.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on Lincoln National Corp's 13F filing for Q2 2022, filed 2 Aug 2022.